Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-006281
Filing Date
2023-02-02
Accepted
2023-02-02 17:26:28
Documents
1
Period of Report
2023-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3804
  Complete submission text file 0001209191-23-006281.txt   5175
Mailing Address 12780 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12780 EL CAMINO REAL SAN DIEGO CA 92130 (858) 617-7600
NEUROCRINE BIOSCIENCES INC (Issuer) CIK: 0000914475 (see all company filings)

EIN.: 330525145 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O NEUROCRINE BIOSCIENCES, INC. 12780 EL CAMINO REAL SAN DIEGO CA 92130
Business Address
Onyia Jude (Reporting) CIK: 0001894425 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-22705 | Film No.: 23582391